1. Home
  2. ARLO vs BEAM Comparison

ARLO vs BEAM Comparison

Compare ARLO & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arlo Technologies Inc.

ARLO

Arlo Technologies Inc.

BUY

Current Price

$14.38

Market Cap

2.0B

ML Signal

BUY

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$25.46

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARLO
BEAM
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
ARLO
BEAM
Price
$14.38
$25.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
12
Target Price
$24.00
$48.09
AVG Volume (30 Days)
1.5M
2.3M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$509,572,000.00
$55,701,000.00
Revenue This Year
$4.65
N/A
Revenue Next Year
$7.87
$19.01
P/E Ratio
$421.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.84
$13.53
52 Week High
$19.94
$35.25

Technical Indicators

Market Signals
Indicator
ARLO
BEAM
Relative Strength Index (RSI) 40.33 59.27
Support Level $12.81 $20.23
Resistance Level $13.70 $22.72
Average True Range (ATR) 0.58 1.66
MACD 0.01 0.45
Stochastic Oscillator 48.90 96.90

Price Performance

Historical Comparison
ARLO
BEAM

About ARLO Arlo Technologies Inc.

Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. It combines a cloud infrastructure and mobile app with various smart connected devices to provide users with visibility, insight, and a means to help protect and connect in real-time with the people and things from any location with a Wi-Fi or a cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: